SOURCE-LINKED INTELLIGENCE

eCAP - Ehealth CAPsule for digestive disease diagnostics and therapy

CORDIS · observation · Publication date unknown

nt reported outcome measures. The clinician is able to personalize the test for the patient and receive accurate and meaningful results from this multi-stream data input with interpretation aided by Artificial Intelligence. The universality of the eCAP solution will allow dissemination of advanced GI disease diagnostics to patients and doctors worldwide, including low resource environments. During the project, we will demonstrate eCAP?s clinical value and cost savings using gastroesophageal reflux disease (GERD), a worldwide, common, and extremely costly problem, as a clinical target. Clinical evaluation with health-economics analysis will be conducted in France, Ukraine and Kenya, and a specific education program will be developed to train practitioners to use the novel technology. eCAP builds on several years of R&D by our consortium in the field of implantable capsules for GI disease diagnostics. Its ambition is to facilitate a shift in GI diagnostics from its current unscalable analogue version to a patient centered e-health tool and to make Europe the leader in the rapidly grow

Read original source ↗ Open in workspace

recordType

award

status

SIGNED

region

EU

value

4757957.9

unit

EUR